Details of the Drug Reposition

General Information of This Drug (ID: DMXI03L)

Drug Name
Anti-mesothelin CAR transduced PBL   DMXI03L
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
5 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Pancreatic cancer DISJC981 2C10 Phase 1/2 [1]
Lung cancer DISCM4YA 2C25.0 Phase 1/2 [1]
Mesothelioma DISKWK9M 2C51.2 Phase 1/2 [1]
Ovarian cancer DISZJHAP 2C73 Phase 1/2 [1]
Cervical cancer DISFSHPF 2C77.0 Phase 1/2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT01583686) CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer